Look Under The Hood: PXSG Has 28% Upside

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the PowerShares Russell 2000 Pure Growth Portfolio ETF ( PXSG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $30.02 per unit.

START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

With PXSG trading at a recent price near $23.55 per unit, that means that analysts see 27.52% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of PXSG's underlying holdings with notable upside to their analyst target prices are Paratek Pharmaceuticals Inc ( PRTK), NovoCure Ltd ( NVCR), and Benefitfocus Inc ( BNFT). Although PRTK has traded at a recent price of $11.10/share, the average analyst target is 217.12% higher at $35.20/share. Similarly, NVCR has 118.05% upside from the recent share price of $6.65 if the average analyst target price of $14.50/share is reached, and analysts on average are expecting BNFT to reach a target price of $47.00/share, which is 80.94% above the recent price of $25.98. Below is a twelve month price history chart comparing the stock performance of PRTK, NVCR, and BNFT:

PRTK, NVCR, and BNFT Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

If you liked this article you might like

Notable Two Hundred Day Moving Average Cross - PXSG